MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-OD-02-0001771
Harihar Pharmaceuticals Private Limited
Harihar Pharmaceuticals Private Limited - pharma in Bolangir, Odisha, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹5.32 Cr
▲ 7% YoY
Net profit · FY 2025
₹8.3 Lakh
Net margin 1.6%
EBITDA · FY 2025
₹50.31 Lakh
EBITDA margin 9.5%
Authorised capital
₹18 Lakh
Registered with MCA
Paid-up capital
₹18 Lakh
Issued & subscribed
Open charges
₹1.2 Cr
Satisfied ₹95 Lakh
Company age
37 yrs
Est. 1989
Employees · EPFO
10
Provident fund records
About Harihar Pharmaceuticals Private Limited
Data last updated:
Harihar Pharmaceuticals Private Limited is a private limited company based in Bolangir, Odisha, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 January 1989 and has been in existence for over 37 years.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U24231OR1989PTC002155. Its GSTIN is 21AABCH0238D1ZG (Odisha).
The company has an authorised share capital of ₹18 Lakh and a paid-up capital of ₹18 Lakh. It is led by directors including Kanhaiya Lal Agrawal (Managing Director) and Bibek Goyal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No – 208 Gyan Kunj Daily Market Road Tikrapada, Bolangir, Odisha, India – 767001.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.32 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹8.3 Lakh (net margin 1.6%) and EBITDA of ₹50.31 Lakh (EBITDA margin 9.5%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 16% over five years.
The company has about 10 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1.2 Cr and satisfied charges of ₹95 Lakh on record. Court records list 2 cases involving the company, including 2 filed against it; 1 case is pending.
Harihar Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-OD-02-0001771). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24231OR1989PTC002155
Registration Number 002155
Incorporation Date 04 January 1989
ROC Cuttack
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-OD-02-0001771
Recognitions & Rankings of Harihar Pharmaceuticals
Contact details
Harihar Pharmaceuticals Private Limited's registered office is in Bolangir, Odisha. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Social Media
- Registered AddressPlot No – 208 Gyan Kunj Daily Market Road Tikrapada, Bolangir, Odisha, India – 767001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Harihar Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Harihar Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Harihar Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Harihar Pharmaceuticals Private Limited, buy the company report.
Financials of Harihar Pharmaceuticals Private Limited
FY 2025 filings availableHarihar Pharmaceuticals Private Limited reported revenue of ₹5.32 Cr (up 7% YoY) for FY 2025.
Revenue · FY 2025
₹5.32 Cr ▲ 7%
Net profit · FY 2025
₹8.3 Lakh margin 1.6%
EBITDA · FY 2025
₹50.31 Lakh margin 9.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▼ 1%
5 years · compounded
▲ 16%
EBITDA CAGR growth
1 year
▲ 12%
3 years · compounded
▲ 4%
5 years · compounded
▲ 14%
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 7% growth in the latest year. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹50.31 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.3 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.5% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Harihar Pharmaceuticals Private Limited, buy the company report.
Board of directors of Harihar Pharmaceuticals Private Limited
Harihar Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kanhaiya Lal Agrawal | Managing Director | 11 Jan 2001 | 25 Years 9 Months | Current |
| Bibek Goyal | Director | 18 Aug 2004 | 22 Years 2 Months | Current |
| Binaya Kumar Goyal | Director | 18 Aug 2004 | 22 Years 2 Months | Current |
Peer comparison
Harihar Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| A R K Health Care Pvt Ltd | ₹5.32 Cr (FY 2024) | -34.0% | Manimajra, Chandigarh, India | |||
| Harihar Pharmaceuticals Private Limitedthis company | ₹5.32 Cr (FY 2025) | ₹8.3 Lakh | 1.6% | 7.0% | 10 | Bolangir, Odisha, India |
| Lexus India Limited | ₹5.32 Cr (FY 2024) | 99.0% | New Delhi, Delhi, India | |||
| Lucevida Pharmaceuticals Private Limited | ₹5.31 Cr (FY 2025) | 42.0% | Siliguri, West Bengal, India | |||
| Meticulous Pharmaceticals Private Limited | ₹5.31 Cr (FY 2025) | 36.0% | Uttar Pradesh, India | |||
| Swastik Formulations Private Limited | ₹5.3 Cr (FY 2025) | 13.0% | Uttar Pradesh, India | |||
| Nupur Pharma Private Limited | ₹5.3 Cr (FY 2025) | -6.0% | Delhi, India |
To see the full peer comparison of Harihar Pharmaceuticals Private Limited, buy the company report.
Auditor
Harihar Pharmaceuticals Private Limited is audited by NARENDRA K JAIN & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NARENDRA K JAIN & ASSOCIATES | FY 2023 | 322048E |
Shareholding
The shareholding of Harihar Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Harihar Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.2 Cr
Satisfied charges
₹95 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Nov 2021 | 100513297 | Hdfc Bank Limited | ₹1.2 Cr | Open | |
| 12 Jan 2018 | 100213175 | Idbi Bank Limited | ₹40 Lakh | Satisfied | |
| 16 Dec 2005 | 80041608 | Utkal Gamya Bank | ₹55 Lakh | Satisfied |
To see the full charge records of Harihar Pharmaceuticals Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Harihar Pharmaceuticals Private Limited has 2 court cases on record: 2 filed against it. 1 case is pending and 1 is disposed.
Total cases
2
Filed against the company
2
Pending
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Balangir, Orissa | Court case (2 (c)cc) | Filed against the company by State of Odisha | Pending |
| District court, Nayagarh, Odisha | Court case (2(c)c.c) | Filed against the company by State of Odisha | Disposed |
To see the full case history of Harihar Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Harihar Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Harihar Pharmaceuticals Private Limited has a workforce of 10 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
Employee count
10
Active EPFO establishments
1
GST
Harihar Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21AABCH0238D1ZG | Odisha | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Harihar Pharmaceuticals Private Limited, buy the company report.
Recent activity
Harihar Pharmaceuticals Private Limited has 4 board changes on record since 2001: 3 appointments and 1 cessation. The latest: Kanhaiya Lal Agrawal ceased to be Director on 24 Jan 2022.
AGM
Harihar Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited of Rs. 120.00 Lakh registered on 15 Nov 2021 with Charge ID 100513297 was modified on 02 Sep 2025.
Filing
Harihar Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Cuttack.
Charges
A charge registered on 12 Jan 2018 via Charge ID 100213175 with Idbi Bank Limited was fully satisfied on 05 May 2022.
Ceased
Kanhaiya Lal Agrawal ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 120.00 Lakh with Charge ID 100513297 was registered on 15 Nov 2021.
Charges
A charge registered on 16 Dec 2005 via Charge ID 80041608 with Utkal Gamya Bank was fully satisfied on 05 May 2018.
Charges
A charge with Idbi Bank Limited amounted to Rs. 40.00 Lakh with Charge ID 100213175 was registered on 12 Jan 2018.
Charges
A charge with Utkal Gamya Bank of Rs. 55.00 Lakh registered on 16 Dec 2005 with Charge ID 80041608 was modified on 07 Jan 2008.
Charges
A charge with Utkal Gamya Bank amounted to Rs. 55.00 Lakh with Charge ID 80041608 was registered on 16 Dec 2005.
Appointed
Bibek Goyal was appointed as Director.
Appointed
Binaya Kumar Goyal was appointed as Director.
2 earlier events are in the company report.
Frequently asked questions
Harihar Pharmaceuticals is an active private limited company based in Bolangir, Odisha, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 January 1989 (37+ years old) and is registered under CIN U24231OR1989PTC002155.
Harihar Pharmaceuticals has 3 current directors:
- Kanhaiya Lal Agrawal - Managing Director
- Bibek Goyal - Director
- Binaya Kumar Goyal - Director
The latest financial statements of Harihar Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Harihar Pharmaceuticals is 21AABCH0238D1ZG, registered in Odisha.
The CIN (Corporate Identification Number) of Harihar Pharmaceuticals is U24231OR1989PTC002155. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Harihar Pharmaceuticals has 2 court cases on record: 2 filed against it. 1 is pending.
Harihar Pharmaceuticals was incorporated on 04 January 1989, making it 37+ years old. It is registered with the Registrar of Companies, Cuttack.
The peers of Harihar Pharmaceuticals by revenue are A R K Health Care Pvt Ltd, Lexus India Limited, Lucevida Pharmaceuticals Private Limited, Meticulous Pharmaceticals Private Limited, Swastik Formulations Private Limited and 1 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Kanhaiya Lal Agrawal ceased to be Director on 24 Jan 2022. Bibek Goyal was appointed as Director on 18 Aug 2004. Binaya Kumar Goyal was appointed as Director on 18 Aug 2004. Harihar Pharmaceuticals has 4 board changes on record in total.
Yes, Harihar Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-OD-02-0001771).
The registered office of Harihar Pharmaceuticals is at Plot No – 208 Gyan Kunj Daily Market Road Tikrapada, Bolangir, Odisha, India – 767001.